跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
多力生 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dexamethasone Palmitate Injection
Approved
化学药品
Dexamethasone Palmitate Injection
MITSUBISHI TANABE PHARMA CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
Jul 14, 2020
Approval ID
81u8kAdoms4
Company
MITSUBISHI TANABE PHARMA CORPORATION
Type
化学药品
Approval Details
Approval Id
81u8kAdoms4
Approval Number
国药准字HJ20160168
Generic Name
地塞米松棕榈酸酯注射液
Generic Name En
Dexamethasone Palmitate Injection
Trade Name
多力生
Brand Name
多力生
Drug Type
化学药品
Dosage Form
注射剂
Strength
1ml:4mg(以地塞米松棕榈酸酯计)
Reg Date
2020-07-14
Expired Date
2025-07-13
Company Name
MITSUBISHI TANABE PHARMA CORPORATION
Company Address
3-2-10,Dosho-machi,Chuo-ku,Osaka 541-8505,Japan
Production Company Name
Mitsubishi Tanabe Pharma Korea Co., Ltd.
Production Company Address
80, Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea
Company Detail Path
/organization/mitsubishi-tanabe-pharma-corporation
Production Company Detail Path
/organization/mitsubishi-tanabe-pharma-korea-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 14, 2020
Approval ID
81u8kAdoms4
Type
化学药品
Back to NMPA Approvals